Allens

Healthcare

Increase text sizeDecrease text sizeDefault text size

Audio: D'Arcy v Myriad: The High Court rules on gene patenting

7 October 2015

In brief: The High Court unanimously overturned the Full Federal Court's decision in D'Arcy v Myriad Genetics that isolated genetic material was patentable.

Allens Partner Dr Trevor Davies (view CV) discusses why the High Court overturned the decision and what it means for the biotech industry.

Listen to the interview

For further information, please contact:

Share or Save for later

What are these?

 

To save this publication on your smartphone or
tablet for off-line reading (eg on a plane flight),
we recommend Pocket.

 

 

You can leave a comment on this publication below. Please note, we are not able to provide specific legal advice in this forum. If you would like advice relating to this topic, contact one of the authors directly. Please do not include links to websites or your comment may not be published.

Comment Box is loading comments...